vs

Side-by-side financial comparison of Envela Corp (ELA) and Inotiv, Inc. (NOTV). Click either name above to swap in a different company.

Inotiv, Inc. is the larger business by last-quarter revenue ($120.9M vs $80.5M, roughly 1.5× Envela Corp). Envela Corp runs the higher net margin — 7.4% vs -23.5%, a 30.9% gap on every dollar of revenue. On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs 0.8%). Envela Corp produced more free cash flow last quarter ($-3.7M vs $-10.6M). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs 0.8%).

Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business u...

ELA vs NOTV — Head-to-Head

Bigger by revenue
NOTV
NOTV
1.5× larger
NOTV
$120.9M
$80.5M
ELA
Growing faster (revenue YoY)
ELA
ELA
+65.8% gap
ELA
66.6%
0.8%
NOTV
Higher net margin
ELA
ELA
30.9% more per $
ELA
7.4%
-23.5%
NOTV
More free cash flow
ELA
ELA
$6.9M more FCF
ELA
$-3.7M
$-10.6M
NOTV
Faster 2-yr revenue CAGR
ELA
ELA
Annualised
ELA
42.1%
0.8%
NOTV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ELA
ELA
NOTV
NOTV
Revenue
$80.5M
$120.9M
Net Profit
$6.0M
$-28.4M
Gross Margin
20.5%
Operating Margin
9.4%
-13.5%
Net Margin
7.4%
-23.5%
Revenue YoY
66.6%
0.8%
Net Profit YoY
274.6%
-2.7%
EPS (diluted)
$0.22
$-0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELA
ELA
NOTV
NOTV
Q4 25
$80.5M
$120.9M
Q3 25
$57.4M
$138.1M
Q2 25
$54.9M
$130.7M
Q1 25
$48.3M
$124.3M
Q4 24
$48.3M
$119.9M
Q3 24
$46.9M
$130.4M
Q2 24
$45.3M
$105.8M
Q1 24
$39.9M
$119.0M
Net Profit
ELA
ELA
NOTV
NOTV
Q4 25
$6.0M
$-28.4M
Q3 25
$3.4M
$-8.6M
Q2 25
$2.8M
$-17.6M
Q1 25
$2.5M
$-14.9M
Q4 24
$1.6M
$-27.6M
Q3 24
$1.7M
$-18.9M
Q2 24
$1.6M
$-26.1M
Q1 24
$1.9M
$-48.1M
Gross Margin
ELA
ELA
NOTV
NOTV
Q4 25
20.5%
Q3 25
22.8%
Q2 25
22.6%
Q1 25
24.8%
Q4 24
23.1%
Q3 24
24.4%
Q2 24
25.1%
Q1 24
25.9%
Operating Margin
ELA
ELA
NOTV
NOTV
Q4 25
9.4%
-13.5%
Q3 25
7.3%
-4.9%
Q2 25
5.9%
-4.3%
Q1 25
6.5%
-2.4%
Q4 24
3.9%
-12.9%
Q3 24
4.3%
-10.1%
Q2 24
4.2%
-19.6%
Q1 24
5.9%
-36.2%
Net Margin
ELA
ELA
NOTV
NOTV
Q4 25
7.4%
-23.5%
Q3 25
5.8%
-6.2%
Q2 25
5.0%
-13.5%
Q1 25
5.2%
-12.0%
Q4 24
3.3%
-23.0%
Q3 24
3.6%
-14.5%
Q2 24
3.5%
-24.7%
Q1 24
4.8%
-40.4%
EPS (diluted)
ELA
ELA
NOTV
NOTV
Q4 25
$0.22
$-0.83
Q3 25
$0.13
$-0.14
Q2 25
$0.11
$-0.51
Q1 25
$0.10
$-0.44
Q4 24
$0.07
$-1.02
Q3 24
$0.06
$-0.73
Q2 24
$0.06
$-1.00
Q1 24
$0.07
$-1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELA
ELA
NOTV
NOTV
Cash + ST InvestmentsLiquidity on hand
$12.7M
Total DebtLower is stronger
$9.9M
$405.8M
Stockholders' EquityBook value
$67.1M
$109.0M
Total Assets
$96.0M
$734.3M
Debt / EquityLower = less leverage
0.15×
3.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELA
ELA
NOTV
NOTV
Q4 25
$12.7M
Q3 25
$21.7M
Q2 25
$6.2M
Q1 25
$19.3M
Q4 24
$38.0M
Q3 24
$21.4M
Q2 24
$14.4M
Q1 24
$19.8M
$32.7M
Total Debt
ELA
ELA
NOTV
NOTV
Q4 25
$9.9M
$405.8M
Q3 25
$12.5M
$402.1M
Q2 25
$13.0M
$396.5M
Q1 25
$13.2M
$399.5M
Q4 24
$13.5M
$396.0M
Q3 24
$13.8M
$393.3M
Q2 24
$14.3M
$382.4M
Q1 24
$14.6M
$380.6M
Stockholders' Equity
ELA
ELA
NOTV
NOTV
Q4 25
$67.1M
$109.0M
Q3 25
$61.1M
$136.0M
Q2 25
$57.8M
$143.8M
Q1 25
$55.1M
$157.7M
Q4 24
$52.7M
$169.8M
Q3 24
$51.1M
$170.5M
Q2 24
$50.2M
$182.1M
Q1 24
$49.3M
$207.2M
Total Assets
ELA
ELA
NOTV
NOTV
Q4 25
$96.0M
$734.3M
Q3 25
$90.9M
$771.1M
Q2 25
$82.7M
$759.7M
Q1 25
$79.7M
$766.0M
Q4 24
$77.9M
$772.9M
Q3 24
$77.4M
$781.4M
Q2 24
$73.8M
$774.6M
Q1 24
$74.7M
$815.4M
Debt / Equity
ELA
ELA
NOTV
NOTV
Q4 25
0.15×
3.72×
Q3 25
0.20×
2.96×
Q2 25
0.23×
2.76×
Q1 25
0.24×
2.53×
Q4 24
0.26×
2.33×
Q3 24
0.27×
2.31×
Q2 24
0.29×
2.10×
Q1 24
0.30×
1.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELA
ELA
NOTV
NOTV
Operating Cash FlowLast quarter
$-3.5M
$-5.4M
Free Cash FlowOCF − Capex
$-3.7M
$-10.6M
FCF MarginFCF / Revenue
-4.6%
-8.8%
Capex IntensityCapex / Revenue
0.2%
4.3%
Cash ConversionOCF / Net Profit
-0.59×
TTM Free Cash FlowTrailing 4 quarters
$1.4M
$-28.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELA
ELA
NOTV
NOTV
Q4 25
$-3.5M
$-5.4M
Q3 25
$2.4M
$14.3M
Q2 25
$2.6M
$-7.4M
Q1 25
$1.1M
$-12.8M
Q4 24
$3.7M
$-4.5M
Q3 24
$3.4M
$-2.4M
Q2 24
$-789.5K
$-14.8M
Q1 24
$3.8M
$16.9M
Free Cash Flow
ELA
ELA
NOTV
NOTV
Q4 25
$-3.7M
$-10.6M
Q3 25
$2.2M
$11.6M
Q2 25
$2.1M
$-11.5M
Q1 25
$746.6K
$-18.3M
Q4 24
$3.2M
$-9.0M
Q3 24
$1.5M
$-7.7M
Q2 24
$-1.3M
$-19.2M
Q1 24
$3.3M
$9.9M
FCF Margin
ELA
ELA
NOTV
NOTV
Q4 25
-4.6%
-8.8%
Q3 25
3.8%
8.4%
Q2 25
3.9%
-8.8%
Q1 25
1.5%
-14.7%
Q4 24
6.7%
-7.5%
Q3 24
3.1%
-5.9%
Q2 24
-2.9%
-18.2%
Q1 24
8.4%
8.3%
Capex Intensity
ELA
ELA
NOTV
NOTV
Q4 25
0.2%
4.3%
Q3 25
0.4%
1.9%
Q2 25
0.8%
3.1%
Q1 25
0.8%
4.4%
Q4 24
1.0%
3.7%
Q3 24
4.2%
4.1%
Q2 24
1.1%
4.2%
Q1 24
1.1%
5.9%
Cash Conversion
ELA
ELA
NOTV
NOTV
Q4 25
-0.59×
Q3 25
0.72×
Q2 25
0.94×
Q1 25
0.45×
Q4 24
2.34×
Q3 24
2.05×
Q2 24
-0.50×
Q1 24
1.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELA
ELA

Consumer Segment$67.7M84%
Commercial Segment$12.8M16%

NOTV
NOTV

Research Models And Services Segment$72.9M60%
Discovery And Safety Assessment Segment$48.0M40%

Related Comparisons